These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 2908303

  • 1. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B, Bompart F, Graham BR, Liu JB, Prichard BN.
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [Abstract] [Full Text] [Related]

  • 2. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
    Tham TC, Guy S, McDermott BJ, Shanks RG, Riddell JG.
    Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
    [Abstract] [Full Text] [Related]

  • 3. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B, Cronin CJ, Graham BR, Prichard BN.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacology of carvedilol.
    Tomlinson B, Prichard BN, Graham BR, Walden RJ.
    Clin Investig; 1992 Jul; 70 Suppl 1():S27-36. PubMed ID: 1350481
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Hashimoto H, Tanaka M, Kanda A, Akashi A.
    Drugs; 1988 Jul; 36 Suppl 6():31-6. PubMed ID: 2908302
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
    Cubeddu LX, Fuenmayor N, Varin F, Villagra VG, Colindres RE, Powell JR.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 11():S81-4. PubMed ID: 2454374
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of carvedilol in normal volunteers.
    Cubeddu LX, Fuenmayor N, Varin F, Villagra VG, Colindres RE, Powell JR.
    Clin Pharmacol Ther; 1987 Jan; 41(1):31-44. PubMed ID: 3802704
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG, Harron DW, Shanks RG.
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
    Nichols AJ, Gellai M, Ruffolo RR.
    Fundam Clin Pharmacol; 1991 Apr; 5(1):25-38. PubMed ID: 1712335
    [Abstract] [Full Text] [Related]

  • 10. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R.
    Acta Med Scand Suppl; 1984 Apr; 689():1-46. PubMed ID: 6151343
    [Abstract] [Full Text] [Related]

  • 11. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
    Giannattasio C, Cattaneo BM, Seravalle G, Carugo S, Mangoni AA, Grassi G, Zanchetti A, Mancia G.
    J Cardiovasc Pharmacol; 1992 Apr; 19 Suppl 1():S18-22. PubMed ID: 1378144
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
    Sponer G, Bartsch W, Strein K, Müller-Beckmann B, Böhm E.
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 14. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC, McKaigue JP, Guy S, Shanks RG, Riddell JG.
    Br J Clin Pharmacol; 1993 Sep 26; 36(3):251-6. PubMed ID: 9114912
    [Abstract] [Full Text] [Related]

  • 15. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T, van der Does R, Schräder R, Landgraf H, Kober G.
    J Cardiovasc Pharmacol; 1987 Sep 26; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [Abstract] [Full Text] [Related]

  • 16. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
    Smith EF, Slivjak MJ, Gagnon R.
    Cardiovasc Drugs Ther; 1992 Oct 26; 6(5):499-504. PubMed ID: 1360255
    [Abstract] [Full Text] [Related]

  • 17. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX, Carr ME, Fuenmayor NJ.
    Clin Pharmacol Ther; 1985 Mar 26; 37(3):277-83. PubMed ID: 2857602
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K, Watanabe TX, Sokabe H.
    Jpn J Pharmacol; 1984 Dec 26; 36(4):519-26. PubMed ID: 6151998
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation.
    Ruffolo RR, Sauermelch CF, Willette RN.
    Eur J Clin Pharmacol; 1990 Dec 26; 38 Suppl 2():S112-4. PubMed ID: 1974499
    [Abstract] [Full Text] [Related]

  • 20. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC, Nelson AH, Ohlstein EH, Willette RN, Sealey JE, Laragh JH, Campbell WG, Feuerstein GZ.
    J Pharmacol Exp Ther; 1996 Nov 26; 279(2):948-55. PubMed ID: 8930204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.